Announced Fri, 17 Jul, 2026 · 14:04 IST

Revised Directors Report submitted for FY25-26 Annual Report

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Next day

₹160.00

prior close

—

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.5%+0.5% vs market

Medical Equipment & Supplies peers, median of 11sector-1.4%+1.4% vs sector

By the next day the stock moved 0.5 pts more than Nifty Microcap 250 and 1.4 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

—-1.1—-1.7—

Next day

+0.0-0.5+0.5-1.4+1.4

-0.6-0.1-0.5+0.0-0.7

—-1.3—-1.6—

—-2.0—-2.5—

—-1.6—-3.0—

—-1.5—-4.7—

15d

—+2.9—-1.5—

—+3.4—-3.2—

—+2.5—+3.0—

—-0.1—-3.1—

UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 11Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Earkart filed a revised Directors Report for FY25-26 with BSE to correct an inadvertent clerical omission. The company clarified the fix does not affect financial results or position. The attached annual report shows total income of Rs 54.14 Cr, up 25.35 percent YoY, but PAT fell 25.75 percent to Rs 4.93 Cr due to higher logistics and listing costs. Company listed on BSE SME in October 2025 after raising Rs 44.7 Cr through IPO.

Likely market impact

Routine clerical correction with no financial impact. Revenue grew strongly but profits dipped on higher costs post-IPO listing.